Influenza virus antigens
Showing 51–70 of 70 results
Influenza A/Massachusetts/18/2022 (H3N2)-like virus hemagglutinin (trimeric)
Influenza A H3N2 hemagglutinin protein produced in HEK293 cells and purified from culture supernatant. The protein contains a C-terminal T4 foldon domain and presents predominantly as trimer. This protein is part of WHO’s recommendation for the composition of influenza virus vaccines for the Southern hemisphere 2024.
Influenza A/Massachusetts/18/2022 (H3N2)-like virus neuraminidase (tetrameric)
Influenza A/Massachusetts/18/2022 (H3N2)-like neuraminidase, N-terminal His-tetrabrachion domain, produced in HEK293 cells and purified by affinity chromatography and dialysis.
Influenza A/Thailand/8/2022 (H3N2)-like virus hemagglutinin (trimeric)
Influenza A H3N2 hemagglutinin protein produced in HEK293 cells and purified from culture supernatant. The protein contains a C-terminal T4 foldon domain and presents predominantly as trimer. This protein is part of WHO’s recommendation for the composition of influenza virus vaccines for the Southern hemisphere 2024.
Influenza A/Victoria/4897/2022 (H1N1)pdm09-like virus neuraminidase, N-terminal His-tetrabrachion domain
Recombinant influenza A/Victoria/4897/2022 (H1N1)pdm09-like virus neuraminidase protein. This protein has its naturally occurring tetrameric presentation stabilized using a N-terminal tetrabrachion domain. The protein was produced in HEK293 cells and purified from culture supernatant of transfected cells.
Influenza A/Wisconsin/588/2019 (H1N1)pdm09-like virus neuraminidase, N-terminal His-tetrabrachion domain
This protein has its naturally occurring tetrameric presentation stabilized using a N-terminal tetrabrachion domain. The protein was produced in HEK293 cells and purified from culture supernatant of transfected cells.
Influenza A/Wisconsin/67/2022 (H1N1)pdm09-like virus; neuraminidase, N-terminal His-tetrabrachion domain
Influenza A/Wisconsin/67/2022 (H1N1)pdm09-like virus; neuraminidase, N-terminal His-tetrabrachion domain, produced in HEK293 cells and purified by affinity chromatography and dialysis.
Influenza B [B/Austria/1359417/2021 (B/Victoria lineage)-like virus] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of B/Austria/1359417/2021 (B/Victoria lineage)-like virus, expressed and purified from HEK293 cells as (AA) 1-529 as a stable trimer and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 southern hemisphere influenza season.
Influenza B [B/Austria/1359417/2021 (B/Victoria lineage)-like virus] Neuraminidase (NA), His-Tag
This Influenza virus neuraminidase protein is derived from the NA sequence of the Influenza B/Austria/1359417/2021 NA, expressing aa 35-466, and fused with a polyhistidine tag at the C-terminus. The influenza virus neuraminidase protein is expressed in HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 southern hemisphere influenza season.
Influenza B [B/Beijing/184/93] Nucleoprotein (NP), His-Tag
Influenza B [B/Beijing/184/93] nucleoprotein (NP) is a recombinant antigen expressed and purified to high purity from Escherichia coli.
Influenza B [B/Massachusetts/2/12] Viral Lysate
This Influenza virus lysate is propagated in the MDCK cell line and purified using sucrose density gradient ultracentrifugation, disrupted in the presence of 0.5% Triton X-100 non-ionic detergent/0.6 M KCl, and heat inactivated.
Influenza B [B/Palermo/4/2013] Hemagglutinin (HA), His-Tag
This Influenza virus hemagglutinin protein is derived from the HA sequence of B/Palermo/4/2013, expressing aa 16-547, and fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is manufactured in HEK293 cells to
Influenza B [B/Phuket/3073/2013 (B/Yamagata Lineage)-Like virus] Hemagglutinin (HA), His-Tag
This Influenza virus hemagglutinin protein is derived from the HA sequence of the B/Phuket/3073/2013 (B/Yamagata Lineage)-Like virus, expressing (AA) 44-466, and fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza B [B/Phuket/3073/2013 (B/Yamagata lineage)-like virus] Hemagglutinin (HA), His-tag
This Influenza virus hemagglutinin protein is derived from the HA sequence of the B/Phuket/3073/2013 (B/Yamagata lineage)-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent vaccines for use in the 2022-23 northern hemisphere influenza season.
Influenza B [B/Phuket/3073/2013 (B/Yamagata lineage)-like virus] Neuraminidase (NA), His-Tag
This Influenza virus neuraminidase protein is derived from the NA sequence of the B/Phuket/3073/2013 (B/Yamagata Lineage)-Like virus, expressing aa 44-466, and fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza B [B/Victoria/35/2013] Neuraminidase (NA), His-Tag
This recombinant influenza virus neuraminidase protein is derived from the NA sequence of B/Victoria/35/2013, expressing aa 44-466, and fused with a polyhistidine tag at the C-terminus. The influenza virus neuraminidase protein is manufactured in HEK293 cells with
Influenza B [B/Washington/02/2019 (B/Victoria lineage)-like virus] Hemagglutinin (HA), His-Tag
This Influenza virus hemagglutinin protein is derived from the HA sequence of the B/Washington/02/2019 (B/Victoria lineage)-like virus, expressing aa 31-469, and fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza B [B/Washington/02/2019] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of B/Washington/02/2019, expressed and purified from HEK293 cells as aa 1-545, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza B [B/Washington/02/2019] Neuraminidase (NA), His-Tag
A recombinant influenza virus neuraminidase protein derived from the NA sequence of Influenza B/Washington/02/2019, expressed and purified from HEK293 cells as aa 44-466, and fused with a polyhistidine tag at the C-terminus. Manufactured in HEK293 cells to This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza B/Austria/1359417/2021 (B/Victoria lineage)-like virus neuraminidase, N-terminal His-tetrabrachion domain
Recombinant influenza B/Austria/1359417/2021 neuraminidase protein. This protein has its naturally occurring tetrameric presentation stabilized using a N-terminal tetrabrachion domain. The protein was produced in HEK293 cells and purified from culture supernatant of transfected cells.
Influenza B/Phuket/3073/2013 (B/Yamagata lineage)-like virus neuraminidase, N-terminal His-tetrabrachion domain
This protein has its naturally occurring tetrameric presentation stabilized using a N-terminal tetrabrachion domain. The protein was produced in HEK293 cells and purified from culture supernatant of transfected cells.
Powered by Bioz